National Drug Early Warning System (NDEWS) Weekly Briefing


Now Available: Q3 2021 RADARS Fentanyl Poisonings

The State and National Overdose Web (SNOW) interactive dashboard is directed by NDEWS Co-Investigator Dr. Bruce Goldberger. SNOW contains information regarding drug-related outcomes in participating NDEWS sentinel sites across the US. SNOW is publicly available and is to be used solely for informational purposes. RADARS (Poison Control) data for quarter 3 is now available. View the dashboard here.

Alert from the NDEWS Web Monitoring Team: Online mentions of 1V-LSD

What was found? A dramatic increase in discussion of the drug 1V-LSD has emerged in recent months with little to no mention prior.

To what does 1V-LSD refer? Several LSD analogs have recently been trending on Reddit. 1V-LSD is one of them.

How is it being discussed? The drug is often mentioned in conjunction with other possible LSD analogs, particularly  “IP LSD”, which may be an alternative term for “1P LSD”. 

Drug Terms: 1V-LSD, Valerie, 1-valeryl-D-lysergic acid diethylamide.

Methodological Note: Data was collected and analyzed by the NDEWS Web Monitoring Team, led by Dr. Elan Barenholtz, PhD candidate Paul Morris and Daniel Van Zant of the Machine Perception and Cognitive Robotics (MPCR) Lab at Florida Atlantic University. Metrics are based on word counts derived from algorithmic monitoring of ~80 drug-oriented Subreddits. No personally identifiable information is incorporated in this monitoring process. For more methodological details, see our recent publication.

Weekly Question:

Is 1V-LSD being used in your area?

Tell NDEWS what you have heard about 1V-LSD use in your area. Click here.


NFLIS-Drug Special Report: Gabapentin and pregabalin reported in NFLIS, 2011-2020

The National Forensic Laboratory Information System (NFLIS) released their annual report this week on results of gabapentin and pregabalin drug cases submitted to state and local laboratories from January 1, 2011 through December 31, 2020. Read the full report here.

E-cigarette use may lead some to quit traditional cigarettes

A recent study examined whether e-cigarette use was associated with quitting cigarette smoking among daily smokers who weren't planning to quit. The team compared quit rates between those who took up e-cigarettes and those who did not. Results showed that those who were using e-cigarettes daily at the end of the study were 8 times more likely to quit cigarettes altogether, and were almost 10 times more likely to stop smoking cigarettes every day. No association was observed between quitting cigarettes and less-than daily e-cigarette use. Read the press release here. Read the full study here.

Suicides by drug overdose increased among young people, elderly people, and Black women, despite overall downward trend

In a study published in the American Journal of Psychiatry, NIDA researchers analyzed data related to overdose deaths classified as intentional, and analyzed data by sex, age, and race/ethnicity, as well as by the month of the year and the day of the week when the overdose occurred. Results suggest an overall decline in suicides by drug overdose in recent years in the US, but an increase among young people aged 15-24, older people aged 75-84, and non-Hispanic Black women. The study also found that women were consistently more likely than men to die from intentional drug overdoses, with the highest rates observed in women ages 45 to 64. Read the press release here. Read the full study here.


Native American tribes reach $590 million deal with J&J and three wholesalers over the opioid crisis

More than 400 tribes and intertribal organizations representing about 80 percent of tribal citizens have sued distribution companies. A $590 million settlement deal has now been made with J&J, AmerisourceBergen, Cardinal Health, and McKesson. Through the deal J&J would pay $150 million over two years, and AmerisourceBergen, Cardinal Health, and McKesson would contribute $440 million in total over seven years. The tribal settlements are part of about $40 billion worth of settlements, penalties, and fines to companies. Read the article here.

Postdoctoral Fellowships Available Immediately!

The University of Florida Substance Abuse Training Center in Public Health T32 is seeking applicants for two postdoctoral fellowship openings! 

- Fellowships are sponsored by the National Institute on Drug Abuse, and postdocs receive an annual stipend and health benefits for 2 years. 

- An annual allowance is offered to facilitate attendance at conferences.

- Fellows would work on NDEWS, the ABCD study or other NIDA funded studies with internationally known mentors.

- UF resources include: CTSA; McKnight Brain Institute; Center on Addiction Research and Education; Arts in Medicine; Pain Research and Intervention Center of Excellence; UF Health Cancer Center; Emerging Pathogens Institute; Institute on Aging

- The T32 program is directed by Dr. Linda Cottler, and co-directed by Dr. Sara Jo Nixon.

Questions should be directed to Ms. Tamara Millay at Applications are considered on a rolling basis; the program values the diversity of its applicants.

Share your research, news, and events through our submission form

Share your comments on our newsletter through our feedback form

Follow NDEWS on Twitter: @NDEWSnews